BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Vaccines

Mongolian Government To Build On COVID-19 Vaccine And Booster Success

Mongolia is preparing to build on the success of its COVID-19 management policies with an ambitious new budget and progressive initiatives as part of ...

December 06, 2021 | News

GenScript, BioComo Join Forces to Accelerate Novel Intranasal SARS-CoV-2 Vaccine Development in Japan

BC-PIV, an innovative non-transmissible viral vector co-developed by BioComo and Mie University, is derived from the recombinant human parainfluenza virus ...

December 03, 2021 | News

Prestige BioPharma Announces Grand Opening of Global-Scale Vaccine Center in South Korea

The opening ceremony was held on December 01, 2021 at the Vaccine Center in Osong Campus. The ceremony was attended by many distinguished guests including ...

December 02, 2021 | News

Novavax Files for Interim Authorization of COVID-19 Vaccine in Singapore

"Today's filing reinforces our ongoing commitment to delivering our COVID-19 vaccine, built on a proven, well-understood vaccine platform, to help end the ...

November 25, 2021 | News

DHL Supply Chain is entrusted by GE Healthcare Japan

DHL Supply Chain (DHL), the global contract logistics leader, has opened five new logistics centers in Japan to support its operations for GE Healthcare Ja...

November 24, 2021 | News

Laos becomes the 20th country to authorize the one-shot Sputnik Light vaccine

Sputnik Light vaccine is based on human adenovirus serotype 26, which is the first component of the Sputnik V vaccine. In March 2021 the two-dose...

November 24, 2021 | News

Novavax Announces Submission of Biologics License Application in South Korea for Approval of NVX-CoV2373

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious dise...

November 23, 2021 | News

Amyris Announces JV Partnership With ImmunityBio For Next Generation COVID-19 RNA Vaccine

The parties have signed a binding term sheet, and a definitive agreement is in process and is expected to be executed within the next month pending standar...

November 09, 2021 | News

Novavax Files COVID-19 Vaccine for EU Listing with WHO

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious dise...

November 05, 2021 | News

Novavax Files COVID-19 Vaccine for Provisional Approval in New Zealand

All modules required for regulatory review of Novavax vaccine, including CMC data, are now complete for Medsafe Novavax, Inc. (Nasdaq: NVAX), a biote...

November 04, 2021 | News

Novavax and Serum Institute of India Receive EUA for COVID-19 Vaccine in Indonesia

"The first authorization of Novavax' COVID-19 vaccine exemplifies our commitment to equitable global access and will fill a vital need for Indonesia, ...

November 02, 2021 | News

Novavax Files for Provisional Approval of its COVID-19 Vaccine in Australia

-- Application marks the first protein-based COVID-19 vaccine submitted to regulatory authorities for provisional approval in Australia --...

November 01, 2021 | News

Why is the WHO delaying an EUL status to Covaxin?

The World Health Organisation usually takes around 6 to 9 weeks to analyse the data submitted by a vaccine manufacturer and then takes a call on whether to...

October 30, 2021 | Opinion | By "Akhil Pathak , an independent writer who keeps an eye on issues related to health, education, society, global politics and defence. He also follows the geo-strategic matters that are directly or indirectly related to the security framework of India."

Hanmi Science Consortium Drives Ambitious Project for Worldwide Vaccine Equity

Hanmi Science doesn't just want the world to know they are committed to vaccine equity, they want to prove it. Mr. Lim, CEO of Hanmi Science, echoes the co...

October 29, 2021 | News

Stay Connected